Pub Date : 2023-08-01DOI: 10.3928/00485713-20230718-01
M. Berk, Vincent Van den Eynde, Karthikeyan Ganapathy, C. Andrade, T. Birkenhäger, J. Bodkin, David Nutt, B. Barnett, Simeon Shalom Feinberg, Gordon Parker, E. Ruhe, M. Fornaro, Charles Redhead, Lila Godet, P. K. Gillman
Experienced clinicians and academics from the International MAOI Expert Group comment on questions of interest concerning monoamine oxidase inhibitor (MAOI) pharmacotherapy for depression. These comments in this Part Two of the Expert Roundtable Discussion emphasize good pharmacological practice, starting with a low dose and progressing slowly and only changing one element at a time. Issues related to augmentation and drug combinations are also mentioned, including comments about the safety of ketamine. The special ability of MAOIs to improve dopamine function is highlighted, especially in relation to melancholic and psychotic depression. [ Psychiatr Ann . 2023;53(8):364–369.]
{"title":"An Expert Roundtable Discussion on the Use of Classic Monoamine Oxidase Inhibitors in the Treatment of Depression – Part Two","authors":"M. Berk, Vincent Van den Eynde, Karthikeyan Ganapathy, C. Andrade, T. Birkenhäger, J. Bodkin, David Nutt, B. Barnett, Simeon Shalom Feinberg, Gordon Parker, E. Ruhe, M. Fornaro, Charles Redhead, Lila Godet, P. K. Gillman","doi":"10.3928/00485713-20230718-01","DOIUrl":"https://doi.org/10.3928/00485713-20230718-01","url":null,"abstract":"\u0000 Experienced clinicians and academics from the International MAOI Expert Group comment on questions of interest concerning monoamine oxidase inhibitor (MAOI) pharmacotherapy for depression. These comments in this Part Two of the Expert Roundtable Discussion emphasize good pharmacological practice, starting with a low dose and progressing slowly and only changing one element at a time. Issues related to augmentation and drug combinations are also mentioned, including comments about the safety of ketamine. The special ability of MAOIs to improve dopamine function is highlighted, especially in relation to melancholic and psychotic depression.\u0000 \u0000 [\u0000 Psychiatr Ann\u0000 . 2023;53(8):364–369.]\u0000 \u0000","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44152513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.3928/00485713-20230207-04
A. Okanlı, Merve İnan Budak, E. Yılmaz, Y. O. Ozdemir
The aim of this study was to evaluate the reliability and validity of the Turkish version of the Stigma Resistance Scale in patients with psychiatric disorders. This methodological study included 190 patients diagnosed with various psychiatric disorders in a psychiatry outpatient clinic of two hospitals in Turkey. The data were analyzed using SPSS and LISREL software. Explanatory and confirmatory factor analyses, Cronbach's alpha coefficients, and test-retest methods were used to determine the validity and reliability of the scale. The Cronbach's alpha coefficient of the scale was 0.89 for the entire scale and ranged between 0.72 and 0.82 for the five subscales; the item-total point correlations were between 0.43 and 0.63; and the correlation value of the test-retest was 0.78. The results of the explanatory factor analysis revealed that a five-factor structure, with factor loadings in the range of 0.44 to 0.70, explained 60.11% of the total variance. According to the results, acceptable adaptation values were computed (χ 2 /SD = 1.840, root-mean-square error of approximation = 0.06, standardized root-mean-square residuals = 0.070, comparative fit index = 0.96). In light of the findings, it was concluded that the Turkish version of the Stigma Resistance Scale could be used as a reliable and valid tool in assessing stigma resistance of Turkish psychiatric patients. Health care professionals may use this instrument in clinical practice to identify patients with mental illness who are experiencing stigma. [ Psychiatr Ann . 2023;53(7):333–339.]
{"title":"Stigma Resistance Scale: A Psychometric Study in a Turkish Mental Illness Sample","authors":"A. Okanlı, Merve İnan Budak, E. Yılmaz, Y. O. Ozdemir","doi":"10.3928/00485713-20230207-04","DOIUrl":"https://doi.org/10.3928/00485713-20230207-04","url":null,"abstract":"\u0000 The aim of this study was to evaluate the reliability and validity of the Turkish version of the Stigma Resistance Scale in patients with psychiatric disorders. This methodological study included 190 patients diagnosed with various psychiatric disorders in a psychiatry outpatient clinic of two hospitals in Turkey. The data were analyzed using SPSS and LISREL software. Explanatory and confirmatory factor analyses, Cronbach's alpha coefficients, and test-retest methods were used to determine the validity and reliability of the scale. The Cronbach's alpha coefficient of the scale was 0.89 for the entire scale and ranged between 0.72 and 0.82 for the five subscales; the item-total point correlations were between 0.43 and 0.63; and the correlation value of the test-retest was 0.78. The results of the explanatory factor analysis revealed that a five-factor structure, with factor loadings in the range of 0.44 to 0.70, explained 60.11% of the total variance. According to the results, acceptable adaptation values were computed (χ\u0000 \u0000 2\u0000 \u0000 /SD = 1.840, root-mean-square error of approximation = 0.06, standardized root-mean-square residuals = 0.070, comparative fit index = 0.96). In light of the findings, it was concluded that the Turkish version of the Stigma Resistance Scale could be used as a reliable and valid tool in assessing stigma resistance of Turkish psychiatric patients. Health care professionals may use this instrument in clinical practice to identify patients with mental illness who are experiencing stigma.\u0000 \u0000 [\u0000 Psychiatr Ann\u0000 . 2023;53(7):333–339.]\u0000 \u0000","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46969789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.3928/00485713-20230619-01
I. Glick
This article presents an overview of the history of psychopharmacology. We speculate on its future development as it bears on psychiatric practice. To do this, we first describe chronologically a history of the reactions to and treatments of the “mentally ill” over time, followed by a short history of groundbreaking developments and advances in clinical medicine. We then examine treatment practices and models of drug development from the past, which provide the foundation for the development of modern psychopharmacology practice. [ Psychiatr Ann . 2023;53(7):305–309.]
{"title":"A Short History of the Field of Psychopharmacology and Its Effects on Psychopharmacology Practice","authors":"I. Glick","doi":"10.3928/00485713-20230619-01","DOIUrl":"https://doi.org/10.3928/00485713-20230619-01","url":null,"abstract":"\u0000 This article presents an overview of the history of psychopharmacology. We speculate on its future development as it bears on psychiatric practice. To do this, we first describe chronologically a history of the reactions to and treatments of the “mentally ill” over time, followed by a short history of groundbreaking developments and advances in clinical medicine. We then examine treatment practices and models of drug development from the past, which provide the foundation for the development of modern psychopharmacology practice.\u0000 \u0000 [\u0000 Psychiatr Ann\u0000 . 2023;53(7):305–309.]\u0000 \u0000","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43388863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.3928/00485713-20230626-01
A. Nierenberg
{"title":"On the Lack, Difficulty, and Need of Reliability in Psychiatry","authors":"A. Nierenberg","doi":"10.3928/00485713-20230626-01","DOIUrl":"https://doi.org/10.3928/00485713-20230626-01","url":null,"abstract":"","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48793903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.3928/00485713-20230526-01
Vaishalee Namdev, A. Polnikov, Tolulope A Fatuki, V. Stetsenko, V. Bellman
Russia has nearly the highest incidence of suicide among children and teenagers in the world. We attempted to create one of the most comprehensive in-depth reviews on this important topic, which is highly relevant for accelerating progress in reducing the thousands of suicides of children and adolescents, most of which are the result of easily preventable or treatable conditions. We analyzed the published data (in both English and Russian) on the prevalence of suicide in minors, current trends related to the phenomenon, and its possible causes. This report shows that suicide is the leading cause of death in Russia for children and teenagers, with the rate among girls exceeding that of boys. The suicide rate in this age category has increased in the last decade and is still growing. We hope that this report will assist health care providers in identifying and managing Russian adolescents at risk for suicide. [ Psychiatr Ann . 2023;53(7):314–324.]
{"title":"Why Hundreds of Russian Teenagers Die Every Year","authors":"Vaishalee Namdev, A. Polnikov, Tolulope A Fatuki, V. Stetsenko, V. Bellman","doi":"10.3928/00485713-20230526-01","DOIUrl":"https://doi.org/10.3928/00485713-20230526-01","url":null,"abstract":"\u0000 Russia has nearly the highest incidence of suicide among children and teenagers in the world. We attempted to create one of the most comprehensive in-depth reviews on this important topic, which is highly relevant for accelerating progress in reducing the thousands of suicides of children and adolescents, most of which are the result of easily preventable or treatable conditions. We analyzed the published data (in both English and Russian) on the prevalence of suicide in minors, current trends related to the phenomenon, and its possible causes. This report shows that suicide is the leading cause of death in Russia for children and teenagers, with the rate among girls exceeding that of boys. The suicide rate in this age category has increased in the last decade and is still growing. We hope that this report will assist health care providers in identifying and managing Russian adolescents at risk for suicide.\u0000 \u0000 [\u0000 Psychiatr Ann\u0000 . 2023;53(7):314–324.]\u0000 \u0000","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46787808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.3928/00485713-20230613-02
Shashank V. Joshi, A. Glowinski
This article highlights the importance of attending to the relational aspects of psychopharmacological work with diverse youth and families. While technical and scientific knowledge remain the focus of medical education, the therapeutic skills known as “nonspecific” treatment factors or “common factors” can also be deconstructed, taught, and examined. [ Psychiatr Ann . 2023;53(7):298–300.]
{"title":"Principles of High-Quality Pediatric Pharmacotherapy","authors":"Shashank V. Joshi, A. Glowinski","doi":"10.3928/00485713-20230613-02","DOIUrl":"https://doi.org/10.3928/00485713-20230613-02","url":null,"abstract":"This article highlights the importance of attending to the relational aspects of psychopharmacological work with diverse youth and families. While technical and scientific knowledge remain the focus of medical education, the therapeutic skills known as “nonspecific” treatment factors or “common factors” can also be deconstructed, taught, and examined.\u0000 \u0000 \u0000 [\u0000 Psychiatr Ann\u0000 . 2023;53(7):298–300.]\u0000 \u0000","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45476906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.3928/00485713-20230607-01
Gonca Buran, S. Çankaya
Menopause is a significant time in the life of women, and they may experience social appearance anxiety in addition to their menopausal complaints during this period. This study aimed to determine the effect of women's menopausal complaints and social appearance anxieties on their level of depression, stress, and anxiety. The sample of this cross-sectional study included women ( n = 305) who applied to the gynecology polyclinic, were between 40 and 65 years old, and had not been menstruating at least for a year. Study data were collected using the following tools: the Menopause Rating Scale (MRS), Social Appearance Anxiety Scale (SAAS), and Depression Anxiety Stress Scale-21 (DASS-21). One unit of increase in the women's total MRS and SAAS scale scores caused 0.597 points of increase in the depression subscale of the DASS-21 scale ( R 2 = 0.135, F (3;304) = 150.962; P < 0.001). As the menopausal complaints and social appearance concerns of women increase during menopause, their stress, anxiety, and depression levels also increase. [ Psychiatr Ann . 2023;53(7):325–332.]
{"title":"Effect of Women's Menopausal Complaints and Social Appearance Anxiety on Their Level of Depression, Stress, and Anxiety: A Cross-Sectional Study","authors":"Gonca Buran, S. Çankaya","doi":"10.3928/00485713-20230607-01","DOIUrl":"https://doi.org/10.3928/00485713-20230607-01","url":null,"abstract":"\u0000 Menopause is a significant time in the life of women, and they may experience social appearance anxiety in addition to their menopausal complaints during this period. This study aimed to determine the effect of women's menopausal complaints and social appearance anxieties on their level of depression, stress, and anxiety. The sample of this cross-sectional study included women (\u0000 n\u0000 = 305) who applied to the gynecology polyclinic, were between 40 and 65 years old, and had not been menstruating at least for a year. Study data were collected using the following tools: the Menopause Rating Scale (MRS), Social Appearance Anxiety Scale (SAAS), and Depression Anxiety Stress Scale-21 (DASS-21). One unit of increase in the women's total MRS and SAAS scale scores caused 0.597 points of increase in the depression subscale of the DASS-21 scale (\u0000 R\u0000 2\u0000 = 0.135,\u0000 F\u0000 (3;304) = 150.962;\u0000 P\u0000 < 0.001). As the menopausal complaints and social appearance concerns of women increase during menopause, their stress, anxiety, and depression levels also increase.\u0000 \u0000 [\u0000 Psychiatr Ann\u0000 . 2023;53(7):325–332.]\u0000 \u0000","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48308462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.3928/00485713-20230614-01
I. Glick
As the science and the data underlying psychopharmacology treatments has become roughly equal to the science underlying medical illness, the level of quality care to achieve psychopharmacology clinical competence in practice has become more difficult for clinicians. This article aims to fill the gap in teaching psychopharmacology and raise the quality level by describing the core tasks for prescribing quality clinical psychopharmacology. We describe reasons why the quality is low, the most common clinical practices that are not being done, and most importantly, delineate the necessary elements for initial and ongoing follow-up visits. The goal is an integrated approach incorporating objective, subjective, and relational factors in psychopharmacology practice. [ Psychiatr Ann . 2023;53(7):294–297.]
{"title":"Improving Efficiency and Effectiveness of Psychopharmacology Practice: What Must Be Done and What Shouldn't Be Done","authors":"I. Glick","doi":"10.3928/00485713-20230614-01","DOIUrl":"https://doi.org/10.3928/00485713-20230614-01","url":null,"abstract":"\u0000 As the science and the data underlying psychopharmacology treatments has become roughly equal to the science underlying medical illness, the level of quality care to achieve psychopharmacology clinical competence in practice has become more difficult for clinicians. This article aims to fill the gap in teaching psychopharmacology and raise the quality level by describing the core tasks for prescribing quality clinical psychopharmacology. We describe reasons why the quality is low, the most common clinical practices that are not being done, and most importantly, delineate the necessary elements for initial and ongoing follow-up visits. The goal is an integrated approach incorporating objective, subjective, and relational factors in psychopharmacology practice.\u0000 \u0000 [\u0000 Psychiatr Ann\u0000 . 2023;53(7):294–297.]\u0000 \u0000","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48852870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.3928/00485713-20230613-01
Danielle Kamis, I. Glick
Mental health is a critical component of overall well-being, yet women face unique challenges when it comes to mental health. Mental illness can present distinctly in women versus men and there are differences of prevalence in specific psychiatric diagnoses as well. The National Institute of Mental Health (NIMH) reports that nearly one in five women in the United States experiences a mental health condition each year. Despite this, women are often underrepresented in clinical trials and may not receive appropriate care for their mental health needs. This article will explore the importance of quality psychopharmacology for women, with a focus on the particular considerations that must be taken into account when treating mental health conditions in women. [ Psychiatr Ann. 2023;53(7):301–304.]
{"title":"Quality Psychopharmacology: Focus on Women","authors":"Danielle Kamis, I. Glick","doi":"10.3928/00485713-20230613-01","DOIUrl":"https://doi.org/10.3928/00485713-20230613-01","url":null,"abstract":"\u0000 Mental health is a critical component of overall well-being, yet women face unique challenges when it comes to mental health. Mental illness can present distinctly in women versus men and there are differences of prevalence in specific psychiatric diagnoses as well. The National Institute of Mental Health (NIMH) reports that nearly one in five women in the United States experiences a mental health condition each year. Despite this, women are often underrepresented in clinical trials and may not receive appropriate care for their mental health needs. This article will explore the importance of quality psychopharmacology for women, with a focus on the particular considerations that must be taken into account when treating mental health conditions in women.\u0000 \u0000 [\u0000 Psychiatr Ann.\u0000 2023;53(7):301–304.]\u0000 \u0000","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45198028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：